Abstract:Background/aims: Methionine restriction (MR) is a dietary intervention that increases lifespan, reduces adiposity and improves insulin sensitivity. These effects are reversed by supplementation of the MR diet with cysteine (MRC). Genomic and metabolomic studies were conducted to identify potential mechanisms by which MR induces favorable metabolic effects, and that are reversed by cysteine supplementation. Methods: Gene expression was examined by microarray analysis and TaqMan quantitative PCR. Levels of selected proteins were measured by Western blot and metabolic intermediates were analyzed by mass spectrometry. Results: MR increased lipid metabolism in inguinal adipose tissue and quadriceps muscle while it decreased lipid synthesis in liver. In inguinal adipose tissue, MR not only caused the transcriptional upregulation of genes associated with fatty acid synthesis but also of Lpin1, Pc, Pck1 and Pdk1, genes that are associated with glyceroneogenesis. MR also upregulated lipolysis-associated genes in inguinal fat and led to increased oxidation in this tissue, as suggested by higher levels of methionine sulfoxide and 13-HODE + 9-HODE compared to control-fed (CF) rats. Moreover, MR caused a trend toward the downregulation of inflammation-associated genes in inguinal adipose tissue. MRC reversed most gene and metabolite changes induced by MR in inguinal adipose tissue, but drove the expression of Elovl6, Lpin1, Pc, and Pdk1 below CF levels. In liver, MR decreased levels of a number of long-chain fatty acids, glycerol and glycerol-3-phosphate corresponding with the gene expression data. Although MR increased the expression of genes associated with carbohydrate metabolism, levels of glycolytic intermediates were below CF levels. MR, however, stimulated gluconeogenesis and ketogenesis in liver tissue. As previously reported, sulfur amino acids derived from methionine were decreased in liver by MR, but homocysteine levels were elevated. Increased liver homocysteine levels by MR were associated with decreased cystathionine β-synthase (CBS) protein levels and lowered vitamin B6 and 5-methyltetrahydrofolate (5MeTHF) content. Finally, MR upregulated fibroblast growth factor 21 (FGF21) gene and protein levels in both liver and adipose tissues. MRC reversed some of MR's effects in liver and upregulated the transcription of genes associated with inflammation and carcinogenesis such as Cxcl16, Cdh17, Mmp12, Mybl1, and Cav1 among others. In quadriceps muscle, MR upregulated lipid metabolism-associated genes and increased 3-hydroxybutyrate levels suggesting increased fatty acid oxidation as well as stimulation of gluconeogenesis and glycogenolysis in this tissue. Conclusion: Increased lipid metabolism in inguinal adipose tissue and quadriceps muscle, decreased triglyceride synthesis in liver and the downregulation of inflammation-associated genes are among the factors that could favor the lean phenotype and increased insulin sensitivity observed in MR rats.

Dietary methionine restriction targets one carbon metabolism in humans and produces broad therapeutic responses in cancer

Dietary Methionine Influences Therapy in Mouse Cancer Models and Alters Human Metabolism

Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response

Dietary methionine restriction in cancer development and antitumor immunity

Dietary methionine restriction impairs anti-tumor immunity through gut microbiota

Methionine Metabolism in Health and Cancer: a Nexus of Diet and Precision Medicine

Methionine restriction beyond life-span extension

Targeting methionine metabolism in cancer: opportunities and challenges

Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota

Physiological and Molecular Mechanisms of Methionine Restriction

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

Methionine-Restricted Diet: A Feasible Strategy Against Chronic or Aging-Related Diseases

Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.

Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet

Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts

Dietary restriction of amino acids for Cancer therapy

Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy

Genomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscle

Methionine Metabolism – A Gateway to Oral Cancer Epigenetics

Cancer Metabolism and Dietary Interventions

Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across species